Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

SOUTH SAN FRANCISCO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in a corporate presentation at the H.C. Wainwright 5^th Annual Neuro Perspectives Conference, being held virtually on Thursday, June 27, 2024.